AnalystsDavid DaiDavid Dai's Stock Forecasts
AnalystsDavid Dai
Sectors:
Industries:
Analyst Ranking
Bottom 9%
#4736 out of 5150 analysts
Average Return
-4.02%
Win Rate
43%12 out of 28
Risk vs Reward
Poor
Good
David Dai's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Jdcom IncJD | +122.61% | $38.35 | $85.37 | 2020-03-16 - 2021-03-17 | Buy |
Syndax Pharmaceuticals IncSNDX | +121.17% | $9.21 | $20.37 | 2025-07-14 - 2025-12-12 | Strong Buy |
Merus NvMRUS | +80.02% | $52.30 | $94.15 | 2024-10-23 - 2025-09-30 | Strong Buy |
Cullinan Therapeutics IncCGEM | +50.70% | $7.91 | $11.92 | 2025-05-12 - 2025-12-12 | Strong Buy |
Nurix Therapeutics IncNRIX | +50.51% | $12.67 | $19.07 | 2025-07-10 - 2025-12-12 | Strong Buy |
David Dai Analyst Color
Get additional color on David Dai's coverage of popular stocks
David Dai's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Perspective Therapeutics IncCATX | 2 | Strong Buy | $7.00 | +162.17% | Maintains | 23 days ago |
Kura Oncology IncKURA | 3 | Strong Buy | $16.00 | +56.56% | Maintains | a month ago |
Biontech SeBNTX | 1 | Hold | $117.00 | +23.40% | Maintains | a month ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $38.00 | +86.55% | Maintains | a month ago |
Nuvalent IncNUVL | 3 | Strong Buy | $132.00 | +25.95% | Maintains | a month ago |
Merus NvMRUS | 2 | Hold | $97.00 | +0.07% | Downgrades | 2 months ago |
Telix Pharmaceuticals LtdTLX | 1 | Strong Buy | $20.00 | +121.48% | Maintains | 3 months ago |
Nurix Therapeutics IncNRIX | 2 | Strong Buy | $26.00 | +36.34% | Maintains | 5 months ago |
Summit Therapeutics IncSMMT | 1 | Strong Buy | $30.00 | +70.75% | Initiates Coverage On | 5 months ago |
Blueprint Medicines CorpBPMC | 2 | Hold | $129.00 | -0.36% | Maintains | 6 months ago |
Iovance Biotherapeutics IncIOVA | 2 | Hold | $2.00 | -9.09% | Downgrades | 7 months ago |
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $24.00 | +101.34% | Maintains | 7 months ago |
Immunocore Holdings PLCIMCR | 1 | Strong Sell | $24.00 | N/A | Initiates Coverage On | a year ago |
Janux Therapeutics IncJANX | 1 | Strong Buy | $69.00 | N/A | Initiates Coverage On | a year ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | a year ago |
Cg Oncology IncCGON | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | a year ago |
Adicet Bio IncACET | 1 | Buy | $28.00 | N/A | Initiates Coverage On | 4 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 4 years ago |
Inhibrx IncINBX1 | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Macrogenics IncMGNX | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Nkarta IncNKTX | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 4 years ago |
Jdcom IncJD | 1 | Buy | $52.00 | N/A | Upgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.